FNBP1 and astrocytoma (excluding glioblastoma): PrognoScan analysis based on GEO data revealed that lower FNBP1 expression associated with a poorer prognosis for diverse cancer types, such as astrocytoma, breast(non-metastasis), blood, lung, ovarian, and skin, while elevated FNBP1 expression correlated with a worse prognosis in colorectal cancer and metastatic breast cancer.